Cargando…

A comparison of five epidemiological models for transmission of SARS-CoV-2 in India

BACKGROUND: Many popular disease transmission models have helped nations respond to the COVID-19 pandemic by informing decisions about pandemic planning, resource allocation, implementation of social distancing measures, lockdowns, and other non-pharmaceutical interventions. We study how five epidem...

Descripción completa

Detalles Bibliográficos
Autores principales: Purkayastha, Soumik, Bhattacharyya, Rupam, Bhaduri, Ritwik, Kundu, Ritoban, Gu, Xuelin, Salvatore, Maxwell, Ray, Debashree, Mishra, Swapnil, Mukherjee, Bhramar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181542/
https://www.ncbi.nlm.nih.gov/pubmed/34098885
http://dx.doi.org/10.1186/s12879-021-06077-9
_version_ 1783704102584188928
author Purkayastha, Soumik
Bhattacharyya, Rupam
Bhaduri, Ritwik
Kundu, Ritoban
Gu, Xuelin
Salvatore, Maxwell
Ray, Debashree
Mishra, Swapnil
Mukherjee, Bhramar
author_facet Purkayastha, Soumik
Bhattacharyya, Rupam
Bhaduri, Ritwik
Kundu, Ritoban
Gu, Xuelin
Salvatore, Maxwell
Ray, Debashree
Mishra, Swapnil
Mukherjee, Bhramar
author_sort Purkayastha, Soumik
collection PubMed
description BACKGROUND: Many popular disease transmission models have helped nations respond to the COVID-19 pandemic by informing decisions about pandemic planning, resource allocation, implementation of social distancing measures, lockdowns, and other non-pharmaceutical interventions. We study how five epidemiological models forecast and assess the course of the pandemic in India: a baseline curve-fitting model, an extended SIR (eSIR) model, two extended SEIR (SAPHIRE and SEIR-fansy) models, and a semi-mechanistic Bayesian hierarchical model (ICM). METHODS: Using COVID-19 case-recovery-death count data reported in India from March 15 to October 15 to train the models, we generate predictions from each of the five models from October 16 to December 31. To compare prediction accuracy with respect to reported cumulative and active case counts and reported cumulative death counts, we compute the symmetric mean absolute prediction error (SMAPE) for each of the five models. For reported cumulative cases and deaths, we compute Pearson’s and Lin’s correlation coefficients to investigate how well the projected and observed reported counts agree. We also present underreporting factors when available, and comment on uncertainty of projections from each model. RESULTS: For active case counts, SMAPE values are 35.14% (SEIR-fansy) and 37.96% (eSIR). For cumulative case counts, SMAPE values are 6.89% (baseline), 6.59% (eSIR), 2.25% (SAPHIRE) and 2.29% (SEIR-fansy). For cumulative death counts, the SMAPE values are 4.74% (SEIR-fansy), 8.94% (eSIR) and 0.77% (ICM). Three models (SAPHIRE, SEIR-fansy and ICM) return total (sum of reported and unreported) cumulative case counts as well. We compute underreporting factors as of October 31 and note that for cumulative cases, the SEIR-fansy model yields an underreporting factor of 7.25 and ICM model yields 4.54 for the same quantity. For total (sum of reported and unreported) cumulative deaths the SEIR-fansy model reports an underreporting factor of 2.97. On October 31, we observe 8.18 million cumulative reported cases, while the projections (in millions) from the baseline model are 8.71 (95% credible interval: 8.63–8.80), while eSIR yields 8.35 (7.19–9.60), SAPHIRE returns 8.17 (7.90–8.52) and SEIR-fansy projects 8.51 (8.18–8.85) million cases. Cumulative case projections from the eSIR model have the highest uncertainty in terms of width of 95% credible intervals, followed by those from SAPHIRE, the baseline model and finally SEIR-fansy. CONCLUSIONS: In this comparative paper, we describe five different models used to study the transmission dynamics of the SARS-Cov-2 virus in India. While simulation studies are the only gold standard way to compare the accuracy of the models, here we were uniquely poised to compare the projected case-counts against observed data on a test period. The largest variability across models is observed in predicting the “total” number of infections including reported and unreported cases (on which we have no validation data). The degree of under-reporting has been a major concern in India and is characterized in this report. Overall, the SEIR-fansy model appeared to be a good choice with publicly available R-package and desired flexibility plus accuracy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06077-9.
format Online
Article
Text
id pubmed-8181542
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81815422021-06-07 A comparison of five epidemiological models for transmission of SARS-CoV-2 in India Purkayastha, Soumik Bhattacharyya, Rupam Bhaduri, Ritwik Kundu, Ritoban Gu, Xuelin Salvatore, Maxwell Ray, Debashree Mishra, Swapnil Mukherjee, Bhramar BMC Infect Dis Review BACKGROUND: Many popular disease transmission models have helped nations respond to the COVID-19 pandemic by informing decisions about pandemic planning, resource allocation, implementation of social distancing measures, lockdowns, and other non-pharmaceutical interventions. We study how five epidemiological models forecast and assess the course of the pandemic in India: a baseline curve-fitting model, an extended SIR (eSIR) model, two extended SEIR (SAPHIRE and SEIR-fansy) models, and a semi-mechanistic Bayesian hierarchical model (ICM). METHODS: Using COVID-19 case-recovery-death count data reported in India from March 15 to October 15 to train the models, we generate predictions from each of the five models from October 16 to December 31. To compare prediction accuracy with respect to reported cumulative and active case counts and reported cumulative death counts, we compute the symmetric mean absolute prediction error (SMAPE) for each of the five models. For reported cumulative cases and deaths, we compute Pearson’s and Lin’s correlation coefficients to investigate how well the projected and observed reported counts agree. We also present underreporting factors when available, and comment on uncertainty of projections from each model. RESULTS: For active case counts, SMAPE values are 35.14% (SEIR-fansy) and 37.96% (eSIR). For cumulative case counts, SMAPE values are 6.89% (baseline), 6.59% (eSIR), 2.25% (SAPHIRE) and 2.29% (SEIR-fansy). For cumulative death counts, the SMAPE values are 4.74% (SEIR-fansy), 8.94% (eSIR) and 0.77% (ICM). Three models (SAPHIRE, SEIR-fansy and ICM) return total (sum of reported and unreported) cumulative case counts as well. We compute underreporting factors as of October 31 and note that for cumulative cases, the SEIR-fansy model yields an underreporting factor of 7.25 and ICM model yields 4.54 for the same quantity. For total (sum of reported and unreported) cumulative deaths the SEIR-fansy model reports an underreporting factor of 2.97. On October 31, we observe 8.18 million cumulative reported cases, while the projections (in millions) from the baseline model are 8.71 (95% credible interval: 8.63–8.80), while eSIR yields 8.35 (7.19–9.60), SAPHIRE returns 8.17 (7.90–8.52) and SEIR-fansy projects 8.51 (8.18–8.85) million cases. Cumulative case projections from the eSIR model have the highest uncertainty in terms of width of 95% credible intervals, followed by those from SAPHIRE, the baseline model and finally SEIR-fansy. CONCLUSIONS: In this comparative paper, we describe five different models used to study the transmission dynamics of the SARS-Cov-2 virus in India. While simulation studies are the only gold standard way to compare the accuracy of the models, here we were uniquely poised to compare the projected case-counts against observed data on a test period. The largest variability across models is observed in predicting the “total” number of infections including reported and unreported cases (on which we have no validation data). The degree of under-reporting has been a major concern in India and is characterized in this report. Overall, the SEIR-fansy model appeared to be a good choice with publicly available R-package and desired flexibility plus accuracy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06077-9. BioMed Central 2021-06-07 /pmc/articles/PMC8181542/ /pubmed/34098885 http://dx.doi.org/10.1186/s12879-021-06077-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Purkayastha, Soumik
Bhattacharyya, Rupam
Bhaduri, Ritwik
Kundu, Ritoban
Gu, Xuelin
Salvatore, Maxwell
Ray, Debashree
Mishra, Swapnil
Mukherjee, Bhramar
A comparison of five epidemiological models for transmission of SARS-CoV-2 in India
title A comparison of five epidemiological models for transmission of SARS-CoV-2 in India
title_full A comparison of five epidemiological models for transmission of SARS-CoV-2 in India
title_fullStr A comparison of five epidemiological models for transmission of SARS-CoV-2 in India
title_full_unstemmed A comparison of five epidemiological models for transmission of SARS-CoV-2 in India
title_short A comparison of five epidemiological models for transmission of SARS-CoV-2 in India
title_sort comparison of five epidemiological models for transmission of sars-cov-2 in india
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181542/
https://www.ncbi.nlm.nih.gov/pubmed/34098885
http://dx.doi.org/10.1186/s12879-021-06077-9
work_keys_str_mv AT purkayasthasoumik acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT bhattacharyyarupam acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT bhaduriritwik acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT kunduritoban acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT guxuelin acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT salvatoremaxwell acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT raydebashree acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT mishraswapnil acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT mukherjeebhramar acomparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT purkayasthasoumik comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT bhattacharyyarupam comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT bhaduriritwik comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT kunduritoban comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT guxuelin comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT salvatoremaxwell comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT raydebashree comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT mishraswapnil comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia
AT mukherjeebhramar comparisonoffiveepidemiologicalmodelsfortransmissionofsarscov2inindia